Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2008 1
2010 1
2011 1
2012 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for metronidazole baxter
Your search for metronidazolo-baxter retrieved no results
Navigating changes in Clostridioides difficile prevention and treatment.
Durham SH, Le P, Cassano AT. Durham SH, et al. J Manag Care Spec Pharm. 2020 Dec;26(12-a Suppl):S3-S23. doi: 10.18553/jmcp.2020.26.12-a.s3. J Manag Care Spec Pharm. 2020. PMID: 33533699 Free PMC article. Review.
The 2017 Infectious Diseases Society of America (IDSA) guidelines made a significant change in treatment recommendations for first time CDI episodes by recommending the use of oral vancomycin or fidaxomicin in place of metronidazole as a first-line treatment. The guideline …
The 2017 Infectious Diseases Society of America (IDSA) guidelines made a significant change in treatment recommendations for first time CDI …
Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
Guay DR, Meatherall RC, Baxter H, Jacyk WR, Penner B. Guay DR, et al. Antimicrob Agents Chemother. 1984 Mar;25(3):306-10. doi: 10.1128/AAC.25.3.306. Antimicrob Agents Chemother. 1984. PMID: 6721462 Free PMC article.
This would suggest that cumulative penetration of metronidazole from the systemic circulation into the peritoneal cavity with dosing every 8 h should lead to adequate concentrations for the treatment of anaerobic peritonitis. For the treatment of systemic anaerobic infecti …
This would suggest that cumulative penetration of metronidazole from the systemic circulation into the peritoneal cavity with dosing …
Treatment with monoclonal antibodies against Clostridium difficile toxins.
Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, Gerding DN, Nichol G, Thomas WD Jr, Leney M, Sloan S, Hay CA, Ambrosino DM. Lowy I, et al. N Engl J Med. 2010 Jan 21;362(3):197-205. doi: 10.1056/NEJMoa0907635. N Engl J Med. 2010. PMID: 20089970 Free article. Clinical Trial.
The antibodies were administered together as a single infusion, each at a dose of 10 mg per kilogram of body weight, in patients with symptomatic C. difficile infection who were receiving either metronidazole or vancomycin. The primary outcome was laboratory-documented rec …
The antibodies were administered together as a single infusion, each at a dose of 10 mg per kilogram of body weight, in patients with sympto …
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
Karlowsky JA, Adam HJ, Baxter MR, Dutka CW, Nichol KA, Laing NM, Golding GR, Zhanel GG. Karlowsky JA, et al. J Antimicrob Chemother. 2020 Jul 1;75(7):1824-1832. doi: 10.1093/jac/dkaa118. J Antimicrob Chemother. 2020. PMID: 32294172
Fidaxomicin MICs were lower than those of all other agents tested (MIC90, 0.5 mg/L); however, one isolate with a fidaxomicin MIC of >8 mg/L was identified. Metronidazole MICs ranged from 0.12 to 4 mg/L; all isolates were metronidazole susceptible by the CLSI brea …
Fidaxomicin MICs were lower than those of all other agents tested (MIC90, 0.5 mg/L); however, one isolate with a fidaxomicin MIC of >8 mg …
Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG. Karlowsky JA, et al. Antimicrob Agents Chemother. 2012 Mar;56(3):1247-52. doi: 10.1128/AAC.05823-11. Epub 2011 Dec 27. Antimicrob Agents Chemother. 2012. PMID: 22203594 Free PMC article.
Overall rates of percent susceptibility were as follows: 99.7%, metronidazole; 99.5%, piperacillin-tazobactam; 99.2%, imipenem; 97.7%, ertapenem; 92.0%, doripenem; 87.3%, amoxicillin-clavulanate; 80.9%, tigecycline; 65.9%, cefoxitin; 55.6%, moxifloxacin; and 52.2%, clindam …
Overall rates of percent susceptibility were as follows: 99.7%, metronidazole; 99.5%, piperacillin-tazobactam; 99.2%, imipenem; 97.7% …
Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
Baxter R, Ray GT, Fireman BH. Baxter R, et al. Infect Control Hosp Epidemiol. 2008 Jan;29(1):44-50. doi: 10.1086/524320. Infect Control Hosp Epidemiol. 2008. PMID: 18171186
RESULTS: The following antibiotics were associated with a significantly increased risk of acquiring CDAD: imipenem-cilastin (odds ratio [OR], 2.77), clindamycin (OR, 2.31), cefuroxime (OR, 2.16), moxifloxacin (OR, 1.88), ceftazidime (OR, 1.82), cefpodoxime (OR, 1.58), ceftizoxime …
RESULTS: The following antibiotics were associated with a significantly increased risk of acquiring CDAD: imipenem-cilastin (odds ratio [OR] …